Affimed
AFMD
AFMD was delisted on the 19th of May, 2025.
32 hedge funds and large institutions have $40.5M invested in Affimed in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
367% more call options, than puts
Call options by funds: $14K | Put options by funds: $3K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
6% more capital invested
Capital invested by funds: $38.1M → $40.5M (+$2.41M)
3% more funds holding
Funds holding: 31 → 32 (+1)
0.13% less ownership
Funds ownership: 4.23% → 4.1% (-0.13%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$817K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$634K |
| 3 |
Renaissance Technologies
New York
|
+$363K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$266K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$171K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$3.19M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$190K |
| 3 |
TI
Telemetry Investments
New York
|
-$117K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$94K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$48K |
AFMD Hedge Fund Activity: Q3 2017 in Review
32 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Affimed (AFMD) for Q3 2017, worth a combined $40.5M — up 6.3% from $38.1M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AFMD positions and 6 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $817K. The largest seller was OrbiMed, cutting an estimated $3.19M.
- 32 institutional investors held Affimed (AFMD) as of Q3 2017, up from 31 in Q2 2017.
- Funds reported $40.5M of Affimed stock for Q3 2017, up 6.3% quarter-over-quarter.
- 8 funds opened new Affimed positions in Q3 2017 and 6 closed out, a net change of +2 holders.
- The largest Affimed buyer in Q3 2017 was Wellington Management Group, an estimated $817K added.
- The largest Affimed seller in Q3 2017 was OrbiMed, an estimated $3.19M sold.
Based on aggregated 13F filings for Q3 2017.